A longitudinal case-control design was used to evaluate the effects of the patient-centered medical home model on medical costs and utilization among chronically ill patients.
This paper describes results from a patient survey regarding treatment-related financial experiences and interest in a financial literacy course.
A framework centered around cost, quality, and equity is essential to define the value of hospital-at-home programs.
The authors used Medicare claims data to examine trends in hospital–physician integration in high-volume specialties, including medical oncology.
Patients who obtained authorization but did not get initial mental health treatment needed treatment as much as or more than patients who presented for care.
Costs of potentially avoidable complications have significantly more variation than costs of typical care in selected chronic and procedural episodes.
Influenza vaccination rates in pregnant women and healthcare workers were increased with standing orders, vaccine advocates, and educational activities on influenza immunization.
This study evaluated a passive clinical pharmacist intervention to reduce the coprescribing of benzodiazepines and opioid analgesics by using chart review notes to alert providers.
Balancing competing goals of innovation and regulatory oversight will influence the evolution of the vendor market for certified ambulatory electronic health record products.
This analysis examines the associations between adherence to Choosing Wisely recommendations embedded into clinical decision support alerts and 4 measures of resource use and quality.
Stereotactic body radiation therapy for low- to intermediate-risk prostate cancer has potential cost savings and may improve access to radiation, increase convenience, and boost quality of life.
State-level estimates of the number of people treated for cancer and the average cost of their treatment by state from 2010 through 2020.
Patients who used workplace primary care and pharmacy services had higher adherence rates to medications for their chronic conditions than community-treated patients.
The Medicaid population has significantly higher hepatitis C virus (HCV) prevalence and mortality rates than patients with private insurance. These data must be considered when policy makers assess providing additional support to Medicaid programs for HCV elimination.